Back to the Top
The following message was posted to: PharmPK
I tried to find some literature about PK variability (i.e. Cmax and AUC) of
subcutaneous depot formulations (here: about 1 week). What range of variability
do I have to expect? Which parameter have the highest influence on the
variability besides the drug itself and the formulation (e.g. injection site,
body fat etc.)? Any hints?
Thanks for your help in advance!
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (email@example.com)